Journal of Health Science and Medical Research,
Journal Year:
2024,
Volume and Issue:
unknown, P. 20231026 - 20231026
Published: Jan. 12, 2024
Objective:
To
determine
the
attitudes
and
perceptions
among
nurses
towards
legalization
of
cannabis
for
medical
use
in
Thailand.Material
Methods:
This
anonymous,
cross-sectional
paper
online
survey
was
conducted
from
May
2020
to
November
2021.
Data
collection
done
using
Cannabis
as
Medicine:
Thai
Nurse’s
Attitudes
Perceptions
Survey.
Descriptive
statistics
were
used
analyze
data.Results:
study
included
287
registered
across
Thailand.
The
top
3
positive
were:
1)
currently,
most
patients
or
intend
oil,
2)
it’s
not
uncommon
if
with
advanced
cancer
decide
3)
a
patient’s
values
beliefs
oil
can
them
feel
better.
negative
reduces
tumor
growth
stages,
administer
other
medications;
(3)
like
taking
care
non-medicinal
cannabis.Conclusion:
more
likely
have
cannabis.
respondents
required
increase
their
knowledge
about
Understanding
nurses’
is
necessary
see
insider
views,
difficulties
they
face,
provide
room
improvement
enhance
benefits
safety
use.
Future
research
larger
sample
sizes
recommended
strengthen
quality
evidence.
Cannabis and Cannabinoid Research,
Journal Year:
2021,
Volume and Issue:
8(1), P. 166 - 173
Published: Nov. 19, 2021
Introduction:
Cannabis
products
containing
delta-8-THC
became
widely
available
in
most
of
the
United
States
late
2020
and
rapidly
a
significant
source
revenue
for
hemp
processing
companies,
especially
states
where
use
delta-9-THC
remains
illegal
or
requires
professional
authorization
medical
use.
Scientific
research
on
is
scarce,
previous
clinical
studies
included
combined
total
14
participants,
leading
some
state
governments
to
prohibit
it
until
its
properties
effects
are
better
understood.
Methods:
Researchers
developed
an
online
survey
consumers
addressing
broad
range
issues
regarding
delta-8-THC,
including
treatment
health
conditions.
Previous
cannabis
informed
components.
Results:
Patterns
had
both
similarities
with
differences
from
products.
Administration
methods
were
primarily
edibles
(64%)
vaping
concentrates
(48%).
About
half
participants
(51%)
used
treat
conditions,
anxiety
panic
attacks
(69%),
stress
(52%),
depression
bipolar
disorder
(46%),
chronic
pain
(41%).
Participants
compared
very
favorably
pharmaceutical
drugs
reported
substantial
levels
substitution
both.
Most
did
not
inform
their
primary
care
provider
(78%)
confident
provider's
ability
integrate
into
(70%).
Knowledge
effective
dosages
was
low,
participants'
knowledge
Internet
own
experiences.
Conclusion:
Harm
reduction
central
component
public
health.
Although
legal
environment
becoming
more
restrictive
comparison
delta-9-THC,
results
suggest
that
may
be
equally
desired
purposes
lower
undesirable
adverse
effects.
All
policies
practices
should
by
empirical
evidence.
Considerable
will
needed
systematically
verify
patterns
collaborations
among
academic
researchers,
government,
industry
valuable
developing
base
other
cannabinoids.
JAMA Network Open,
Journal Year:
2022,
Volume and Issue:
5(5), P. e2211677 - e2211677
Published: May 23, 2022
Importance
Patients
who
use
cannabis
for
medical
reasons
may
benefit
from
discussions
with
clinicians
about
health
risks
of
and
evidence-based
treatment
alternatives.
However,
little
is
known
the
prevalence
in
primary
care
how
often
it
documented
patient
electronic
records
(EHR).
Objective
To
estimate
according
to
confidential
survey
compare
EHR
report.
Design,
Setting,
Participants
This
study
a
cross-sectional
performed
large
system
that
conducts
routine
screening
Washington
state
where
nonmedical
are
legal.
Among
108
950
patients
completed
(between
March
28,
2019,
September
12,
2019),
5000
were
randomly
selected
use,
using
stratified
random
sampling
frequency
past-year
race
ethnicity.
Data
analyzed
November
2020
December
2021.
Exposures
Survey
measures
patient-reported
(ie,
explicit
use),
any
reason(s)
implicit
use).
Main
Outcomes
Measures
data
linked
year
before
screening.
included
documentation
and/or
use.
Analyses
estimated
compared
EHR-documented
accounting
nonresponse.
Results
Overall,
1688
responded
(34%
response
rate;
mean
[SD]
age,
50.7
[17.5]
years;
861
female
[56%],
1184
White
[74%],
1514
non-Hispanic
[97%],
1059
commercially
insured
[65%]).
The
on
was
38.8%
(95%
CI,
31.9%-46.1%),
whereas
26.5%
21.6%-31.3%)
35.1%
29.3%-40.8%),
respectively.
4.8%
3.45%-6.2%).
Compared
sensitivity
specificity
10.0%
4.4%-15.6%)
97.1%
94.4%-99.8%),
Conclusions
Relevance
These
findings
suggest
common
among
legal
most
not
EHR.
Patient
report
identifies
more
questions
Cannabis and Cannabinoid Research,
Journal Year:
2022,
Volume and Issue:
7(4), P. 473 - 481
Published: Jan. 28, 2022
Introduction:
Endometriosis
affects
1
in
10
women
worldwide,
with
most
experiencing
difficulties
achieving
adequate
symptom
control.
These
have
been
compounded
by
the
onset
of
COVID-19
pandemic
due
to
worldwide
shifts
health
care
resource
allocation.
As
cannabis
is
a
relatively
common
form
self-management
endometriosis,
this
study
aims
explore
impact
on
consumption
those
endometriosis.
Methods:
An
anonymous,
cross-sectional
online
international
survey
was
developed
and
promoted
endometriosis
advocacy/support
organizations
worldwide.
Respondents
needed
diagnosis
be
aged
between
18
55.
Results:
A
total
1634
responses
were
received
from
46
different
countries.
The
average
age
respondents
30,
mean
25.
Eight
hundred
forty-six
(51%)
reported
consuming
past
3
months,
55%
these
reporting
use
for
management
only.
One
five
(20%)
having
consumed
previously,
reason
discontinuation
(65%)
access
during
COVID.
Those
who
had
legal
more
likely
consume
than
without
(p<0.0001)
disclose
usage
professionals
(p<0.0001).
reasons
COVID
increased
stress/anxiety
(59%)
lack
normal
medical
(48%).
Pre-pandemic,
mostly
at
least
once
day
(61%)
inhaled
forms
(51.6%).
Consumption
people
(57%)
pandemic.
During
just
under
quarter
(23%)
changed
their
mode
consumption,
reduction
(39.5%)
an
increase
edibles
(40%)
or
oil
(25.2%).
Conclusions:
Cannabis
especially
relief,
among
some
starting
restrictions
that
occurred
Difficulties
accessing
unpleasant/unwanted
side
effects
current
previously
it.
may
important
part
when
routine
restricted.
PEC Innovation,
Journal Year:
2021,
Volume and Issue:
1, P. 100009 - 100009
Published: Dec. 3, 2021
This
research
explores
the
impact
of
patient
education
on
reducing
historical
and
current
stigma.Participants
were
recruited
through
social
media,
parenting
with
community
organizations,
snowball
sampling.
A
pretest
posttest
method
was
utilized.
Participants
viewed
five
balanced
educational
videos
about
medicinal
cannabis.
Attitudes
toward
medical
cannabis
measured
a
modified
version
component
Recreational
Medical
Cannabis
Scale
(RMCAS).
In
total,
111
participants
completed
all
requirements
study.Results
Wilcoxon
Sign
Rank
Test
demonstrated
significant
increase
in
RMCAS
(1.18,
p
=
0.029).Health
is
an
effective
intervention
to
reduce
stigma
associated
Future
health
policies
must
take
balanced,
education-focused,
proactive
stance
barriers
care
that
exist
due
negative
use.Innovation:
Historically,
has
focused
areas
such
as
tobacco,
automobile
safety,
vaccinations,
obesity,
like.
applied
area
improve
attitudes
it
access.
Cannabis and Cannabinoid Research,
Journal Year:
2022,
Volume and Issue:
7(4), P. 464 - 472
Published: Jan. 3, 2022
Introduction:
Endometriosis
is
a
difficult
to
manage
condition
associated
with
significant
disease
burden.
High
levels
of
illicit
cannabis
use
for
therapeutic
purposes
have
been
previously
reported
by
endometriosis
patients
in
Australia
and
New
Zealand
(NZ).
Although
access
legal
medicinal
(MC)
available
through
medical
prescription
via
multiple
federal
schemes,
barriers
patient
remain.
Methods:
An
anonymous
cross-sectional
online
survey
was
developed
distributed
social
media
advocacy
groups
worldwide.
Respondents
were
asked
about
versus
usage,
their
understanding
pathways
status,
interactions
health
care
professionals.
Results:
Of
237
respondents
who
diagnosis
endometriosis,
186
(72.0%)
Australian
51
(88.2%)
NZ
self-administering
illicitly.
Only
23.1%
5.9%
accessed
doctor's
prescription,
4.8%
no
reporting
legally
self-administer
cannabis.
Substantial
substitution
effects
(>50%
reduction)
observed
users
nonopioid
analgesia
(63.1%),
opioid
(66.1%),
hormonal
therapies
(27.5%),
antineuropathics
(61.7%),
antidepressants
(28.2%)
antianxiety
medications
(47.9%).
respondents,
18.8%
23.5%
not
disclosing
doctor,
citing
concern
over
repercussions,
societal
judgment,
or
doctors'
reaction
presumed
unwillingness
prescribe
MC.
Conclusions:
self-reported
positive
outcomes
when
using
management
demonstrating
potential
Despite
this,
many
are
without
supervision.
While
evidence
substantial
effect
demonstrated
these
data,
particular
the
clinical
consequences
supervision,
particularly
regard
drug
tapering
cessation
certain
that
Improving
doctor
communication
MC
may
improve
oversight,
preference
adoption
acquisition
supply
reducing
cannabis-associated
stigma.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(3), P. e0295858 - e0295858
Published: March 7, 2024
Background
In
Canada,
cannabis
legalization
altered
the
way
that
public
can
access
for
medical
purposes.
However,
Canadians
still
struggle
with
finding
healthcare
professionals
(HCPs)
who
are
involved
in
counselling
and
authorization.
This
raises
questions
about
barriers
causing
this
breakdown
care.
Our
study
explored
perceptions
of
primary
care
providers
regarding
their
practice.
Methods
Semi-structured
interviews
were
conducted
by
Zoom
HCPs
Newfoundland
Labrador
(NL)
to
discuss
experiences
non-medical
Family
physicians
nurse
practitioners
practicing
NL
included.
The
interview
guide
coding
template
developed
using
Theoretical
Domains
Framework
(TDF).
A
thematic
analysis
across
TDF
was
then
conducted.
Results
Twelve
participants
diverse
demographic
backgrounds
experience
levels
interviewed.
Five
main
themes
emerged
including,
knowledge
acquisition,
internal
influences,
patient
external
HCP
systemic
influences.
domain
resulting
greatest
representation
codes
environmental
context
resources.
Interpretation
findings
suggested
have
significant
gaps
authorizing
cannabis,
which
limited
practice
competence
confidence
area.
Referring
patients
clinics,
while
enforcing
harm-reduction
strategies,
an
interim
option
developing
guidelines
educational
resources
as
prominent
facilitators
promote
authorization
within
system.
Journal of Cannabis Research,
Journal Year:
2025,
Volume and Issue:
7(1)
Published: Jan. 25, 2025
Abstract
Introduction
Chronic
pain
is
common
among
Veterans,
some
of
whom
use
cannabis
for
pain.
We
conducted
a
feasibility
pilot
study
novel
coaching
intervention
to
help
Veterans
optimize
medical
products
management
(NCT06320470).
Methods
The
drew
from
scientific
literature,
consultation
with
experts,
Veteran
input
via
Community
Advisory
Board,
and
tenets
motivational
interviewing.
Participants
were
chronic
who
endorsed
current
or
interest
in
using
management.
received
up
4
individual
sessions
videoconference,
spaced
approximately
2
weeks
apart.
assessed
(adherence,
satisfaction,
acceptability)
preliminary
effects
on
symptoms
14
after
baseline.
primary
outcome
was
the
Patient
Global
Impression
Change
(PGIC),
exploratory
outcomes
included
domains
Patient-Reported
Outcomes
Measurement
Information
System
(PROMIS)-29.
Results
Of
22
enrolled
participants,
17
attended
sessions,
3
sessions.
Among
those
completed
end
surveys
(16/21),
87.5%
very
completely
satisfied
81.3%
rated
as
extremely
helpful.
All
participants
reported
improvement
PGIC,
63%
reporting
much
improvement.
statistically
significant
decreased
intensity
(7.1/10
vs.
5.7/10)
interference
(T-score
66.3
61.8),
increased
social
satisfaction
41.4
44.3).
noted
helpful
factors,
including
co-developing
personalized
plan,
discussing
questions/concerns,
trying
different
approaches
cannabis-based
treatment.
Conclusions
In
this
clinically
improvements
symptoms.
Our
results
support
evaluating
larger,
efficacy
trial.
Oxford University Press eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 7, 2023
Abstract
Visions
of
Cannabis
Control
documents
the
history
cannabis
policy
and
role
racism,
labelling,
stigmatization.
The
book
argues
that
these
problems
stem
from
failure
to
properly
frame
prohibition
as
result
moral
panics
have
been
instigated,
perpetuated,
sustained
in
ways
are
difficult
dislodge.
Stan
Cohen
argued
reforms
designed
replace
carceral
tendencies
within
correctional
institutions
often
extend
such
approaches
into
our
communities.
idea
criminal
justice
reproduce
what
they
were
intended
disrupt
is
depressing
provocative.
It
remains
relevant
revolution
currently
underway
around
world.
Racial
disparities
arrests
persist,
exacerbated
by
laws
make
it
legal
possess
but
illegal
consume
anywhere
your
home.
Too
often,
liberalization
comes
at
cost
expanding
paternalistic
public
health
models
abstention-based
diversion
programs.
Finally,
goal
dismantling
disrupting
illicit
markets
has
undermined
onerous
regulations,
anemic
marketing
efforts,
promote
consumer-centered
approaches.
Emphasizing
goals
ahead
market
conditions
complicates
an
industry.
To
understand
future
policy,
examines
experience
six
countries
several
US
states
through
lens
criminological
theory,
recent
research,
practice.
presents
options
guide
responsible
regulation
extensive
research
practice,
finally
concluding
sustaining
reform
will
require
ensuring
those
affected
policies
consulted,
respected,
included.
PEC Innovation,
Journal Year:
2022,
Volume and Issue:
1, P. 100044 - 100044
Published: April 28, 2022
Federal
hemp
legalization
and
ongoing
shifts
in
US
marijuana
laws
have
led
to
increased
population-wide
use
of
cannabidiol
(CBD)
supplements,
often
without
the
knowledge
primary
healthcare
providers
(PCPs).
Given
potential
risks
related
CBD
use,
especially
vulnerable
subgroups,
improved
communication
is
warranted.
This
study
aimed
examine
PCP
attitudes,
experiences,
practice
behaviors
provider-reported
barriers
with
patients
about
use.
Fourteen
PCPs
were
recruited
participated
semi-structured
interviews.
Transcripts
digitally
analyzed
using
inductive
thematic
analysis.
Analyses
identified
that
most
had
neutral
views
by
their
patients.
The
found
discussions
initiated
Most
cited
lack
time,
discomfort,
low-quality
evidence,
low
prioritization
as
reasons
for
not
discussing
rarely
screen
or
discuss
them
A
number
exist
open
dialogue
CBD.
Our
first
in-depth
report
on
findings
our
significantly
impact
future
behaviors.
These
results
can
inform
system
policies
around
screening
training.
In
doing
so,
these
efforts
may
mitigate
risk
optimize
benefits
expanding
market.
Journal of Cannabis Research,
Journal Year:
2022,
Volume and Issue:
4(1)
Published: June 13, 2022
Abstract
Background
Patients
use
medical
cannabis
for
a
wide
array
of
illnesses
and
symptoms,
many
substitute
pharmaceuticals.
This
substitution
often
occurs
without
physician
oversight,
raising
patient
safety
concerns.
We
aimed
to
characterize
doctor-patient
communication
patterns
in
Canada,
where
there
is
mature
market
national
regulatory
system
cannabis.
Methods
conducted
an
anonymous,
cross-sectional
online
survey
May
2021
seven
days
with
adult
Canadian
federally-authorized
patients
(
N
=
2697)
registered
two
global
companies
evaluate
perceptions
Primary
Care
Provider
(PCP)
knowledge
regarding
PCPs,
including
PCP
authorization
licensure
other
medications.
Results
Most
participants
(62.7%,
n
1390)
obtained
from
their
PCP.
Of
those
who
spoke
about
(82.2%,
2217),
38.6%
857)
reported
that
had
“very
good”
or
“excellent”
and,
on
average,
were
moderately
confident
PCP’s
ability
integrate
into
treatment.
Participants
generally
higher
ratings
secondary
care
providers,
82.8%
808)
rating
provider’s
as
“excellent.”
Overall,
47.1%
1269)
substituting
pharmaceuticals
substances
(e.g.,
alcohol,
tobacco/nicotine).
these,
31.3%
397)
delay
informing
up
6
months
more,
34.8%
441)
was
still
not
aware
substitution.
Older,
female
odds
disclosing
PCPs.
Conclusion
the
surveyed
considered
PCPs
knowledgeable
PCPs’
treatment
plans.
However,
substituted
medications
consulting
These
results
suggest
lack
integration
between
mainstream
healthcare
may
be
improved
through
education
clinical
experience.